Novochizol SA

Novochizol™ technology quantitatively transforms single linear chitosan molecules into uniformly sized nanoparticles that can be used alone, as emulsifiers or carriers of active ingredients. Novochizol™ overcomes the limitations of chitosan, enhances its existing beneficial properties and displays new characteristics: - Formulation of all API classes: small molecules, peptides, nucleic acids, proteins, viruses and cells. - Low viscosity solutions/suspensions under all conditions - Administration-targeted drug release, without systemic distribution - Customizable sustained release properties - Slow biodegradation and physical robustness - Intracellular delivery of active ingredients, including proteins.

Website

http://www.novochizol.ch

Externer Link zu Novochizol SA

Branche

Biotechnologieforschung

Größe

2–10 Beschäftigte

Hauptsitz

Monthey , Valais

Art

Privatunternehmen

Gegründet

2021